0001171843-16-009701 Sample Contracts

SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • May 5th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Securities Purchase Agreement
• Filed
  May 5th, 2016
• Company
  Sucampo Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 9, 2016 by and between Cancer Prevention Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Sucampo AG, a Swiss corporation, and a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc., a Delaware corporation (together, the “Purchaser”).

SEPARATION AGREEMENT AND RELEASES

Separation Agreement • May 5th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Separation Agreement
• Filed
  May 5th, 2016
• Company
  Sucampo Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

This Separation Agreement and Releases (“Separation Agreement”) is made and entered into as of the 29th day of February, 2016, by and between Stanley Miele (hereinafter “Executive”) and Sucampo Pharmaceuticals, Inc. (“SPI”), a corporation organized under the laws of the State of Delaware, and its affiliates (hereinafter collectively referred to as the “Company”).

EMPLOYMENT AGREEMENT

Employment Agreement • May 5th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Employment Agreement
• Filed
  May 5th, 2016
• Company
  Sucampo Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

2015, is hereby entered into in the State of Maryland by and between SUCAMPO PHARMACEUTICALS, INC., a Delaware limited liability company (the "Company"), and Andrew Smith ("Executive").

OPTION AND COLLABORATION AGREEMENT

Option and Collaboration Agreement • May 5th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Option and Collaboration Agreement
• Filed
  May 5th, 2016
• Company
  Sucampo Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Option and Collaboration Agreement (“Agreement”) dated 9th day of January, 2016 (“Effective Date”) by and between Cancer Prevention Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware, having a place of business at 1760 East River Road, Suite 250, Tucson, Arizona 85718 (“CPP”), and Sucampo AG, a corporation organized and existing under the laws of Switzerland, having a place of business at Baarerstrasse 22, 6300 Zug, Switzerland (“Sucampo”). CPP and Sucampo are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”